

Metastatic Breast Cancer
Oct 17, 2022
Explore systemic therapy guidelines for metastatic breast cancer, CDK4-6 inhibitors toxicities, second-line treatments, HER2 positive treatment options, triple negative strategies, and emerging research in the field.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Exploring CDK4-6 Inhibitors Toxicities and Second-Line Treatment Options
01:54 • 3min
Exploring Treatment Options for HER2 Positive Metastatic Breast Cancer
04:28 • 2min
Treatment Strategies for Triple Negative Metastatic Breast Cancer
06:06 • 2min
In-depth Discussion on Metastatic Breast Cancer Treatment and Emerging Research
07:42 • 3min